Sentence: The levels of 3 NF-kappaB transcription factors , the activating inhibitors of NF-kappaB ( IkappaB ) kinases , and the NF-kappaB target matrix metalloproteinase 9 ( MMP9 ) were assessed by immunohistochemistry in specimens of ovarian cancer that were obtained at diagnosis from a cohort of 33 patients who subsequently received combined paclitaxel , cisplatin , and cyclophosphamide .
Drug combination annotation:
[{'class': 'COMB', 'spans': ['paclitaxel', 'cyclophosphamide', 'cisplatin'], 'is_context_needed': True}]